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Abstract  
Concerns are frequently raised about the extent to which formal consent procedures 
actually lead to “informed” consent. As part of a study of consent to high-risk medical 
procedures, we analyzed in-depth interviews with 16 health care professionals working in 
bone-marrow transplantation in Sydney, Australia. We find that these professionals 
recognize and act on their responsibility to inform and educate patients and that they 
expect patients to reciprocate these efforts by demonstrably engaging in the education 
process. This expectation is largely implicit, however, and when it is not met, this can give 
rise to trouble that can have adverse consequences for patients, physicians, and 
relationships within the clinic. We revisit the concept of the sick role to formalize this new 
role expectation, and we argue that “informed” consent is a process that is usually 
incomplete, despite trappings and assumptions that help to create the illusion of 
completeness.  
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Introduction 
Health care professionals have long struggled with how best to incorporate appropriate and 
thorough consent processes into their interactions with patients prior to medical treatment. 
To this end, most health care organizations and professional groups have developed 
standardized routines and legalistic documents for patients to sign upon hospital admission 
and/or before treatment begins. Concerns are frequently expressed, however, by health 
care professionals and also by scholars in legal studies, bioethics, and the social sciences 
about the extent to which these formalized procedures actually lead to “informed” consent. 
Scholars in the sociological literature have recently sought to highlight problems in the 
practice of consent by focusing on the intersection between bioethics and social science. 
Bosk (2010), for example, argues that medical sociologists have exposed a rift between 
principle and practice in consent processes: Whilst the discourse of bioethics focuses on 
basic principles such as respect for autonomy (e.g., Beauchamp and Childress 2009), 
empirical sociological research in the 1970s showed how the reality of knowledge 
asymmetry between patients and physicians acts as a practical barrier to patients’ decisional 
authority, and thereby “demonstrated how much a more muscular concept of informed 
consent was needed in clinical and experimental settings” (Bosk 2010, p. S142). 
In this paper, we extend this line of inquiry by focusing on the nexus between 
consent and the sick role (Parsons 1951; Parsons 1975). Each of these concepts on its own 
has generated a substantial literature, but the two are seldom considered together. Our 
overarching argument is as follows: As the practice of obtaining consent has become 
embedded in formal organizational practices in the clinic (partly in response to legal 
developments [National Health and Medical Research Council 2004a, 1] and pressures for 
more formalized professional codes of conduct), a strengthened version of consent has in 
fact emerged in recent years—one that is frequently referred to as “informed consent”—
and this has placed new expectations on patients. However, these expectations are neither 
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well recognized, nor articulated in a way that produces a satisfactory conclusion to the 
consent process, especially for high-risk medical procedures. We propose that revisiting the 
concept of the sick role offers a fruitful avenue for theorizing about, and formalizing, this 
new role expectation.  
To flesh out this argument, we briefly offer an overview of the concept of consent as 
it is formulated in bioethics (Beauchamp and Childress 2009; Kerridge, Lowe, and Stewart 
2009) and of the sick role (Parsons 1951; Parsons 1975). We then turn to a clinical setting 
where consent poses a significant challenge, in order to present empirical evidence of some 
of our claims. In the concluding section, we discuss theoretical extensions and offer 
observations about how insights from this approach can be incorporated into medical 
practice. 
 
Theoretical Framework 
Biomedical Ethics and Expectations on Professionals 
The discourse of biomedical ethics is primarily concerned with prescribing how sick people 
and research participants should be treated. It aims to prevent harm to these parties, whom 
it frames as vulnerable and whose autonomy is held to be a primary concern and of 
paramount value. Importantly, the threat of harm is seen to emanate from within 
relationships between patients and medical professionals and researchers. The reason for 
this is historical. The development of biomedical ethics in the 20th century was spurred by 
moral outrage over the role of physicians in human experiments conducted under the Nazi 
regime. Thus, it is no coincidence that the section on informed consent in the standard 
biomedical ethics text (Beauchamp and Childress 2009) is nested in the chapter on 
autonomy, which takes the Nuremberg trials as its point of departure.  
Seeking consent for medical treatment is one of the main ways in which the principle 
of respect of autonomy finds expression in medical practice. When applied to medical 
treatment, consent generally refers to an autonomous authorization given by a patient for a 
specific medical procedure. The concept is commonly explicated in terms of several 
elements—those that concern the validity of consent and those that concern information 
(e.g., Beauchamp and Childress 2009; Kerridge, Lowe, and Stewart 2009). The validity of 
consent is vouchsafed by ensuring (i) that it is given voluntarily and (ii) that the person giving 
it is mentally competent. The criterion of voluntariness is a bulwark against coercion (i.e., 
consent obtained by coercive means is invalid). The criterion of mental competence is a 
bulwark against exploitation (i.e., consent obtained from someone who is not mentally 
competent is also invalid). 
In addition to these elements of validity, consent entails elements that concern 
information in the form of (iii) disclosure and (iv) understanding. Disclosure refers to a duty 
that clinicians have to inform patients about (in particular) the risks and benefits of the 
treatments or procedures being considered. Understanding refers to the subjective 
outcome of activities that clinicians undertake to fulfill their duty to inform patients.  
In recent years, greater emphasis has come to be placed on the informational 
elements of consent. The most tangible sign of this trend is the expansion of consent forms 
themselves to include detailed information, especially about the possible risks of treatment. 
The significance of this trend becomes clearer if we consider how the elements of consent 
that concern validity differ conceptually from those that concern information. Voluntariness 
and competence are protective of autonomy—they defend against threats to it—whereas 
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disclosure and understanding are productive of autonomy—they augment it by redressing 
the knowledge asymmetry in the doctor–patient relationship. The difference is between a 
reactive process and an active one. The increasing emphasis on the active, informational 
elements of consent is in keeping with the tenets of patient-centered care, which aim to 
facilitate and encourage the involvement of patients in their own care and increase their 
decisional authority. Thus the intensification of efforts to inform and educate patients more 
broadly can be seen as a trend that serves to strengthen consent by increasing the degree to 
which it is “informed.” 
Of the four elements of consent, in practice the greatest uncertainty surrounds the 
element of understanding. How can physicians know whether and to what extent their 
patients understand the information that is given to them? There is a growing literature on 
how to improve patient understanding during the informed consent process (see, for 
example, Flory and Emanuel 2004; Schenker et al. 2011; Schenker and Meisel 2011), but it 
tends to focus on interventions and techniques that the health professionals can use to 
enhance communication (Schenker et al. 2011). This literature has yet to engage with the 
issue of changing norms and expectations about patient behavior in the consent process. 
We contend that the intensification of efforts to inform and educate patients has placed 
new expectations on patients, but that patients are often unaware of these expectations 
because they are largely implicit. Further, we will argue that trouble arises when these 
expectations are not met. To illustrate this part of the argument, we draw on the concept of 
the sick role. 
The Sick Role and Expectations on Patients 
If bioethics is primarily concerned with how patients and research subjects should be 
treated, medical sociology is primarily concerned with how they are treated, and the sick 
role (Parsons 1951) is a seminal concept in this field. According to the Functionalist school of 
sociology from which this concept derives, health is necessary for the smooth functioning of 
society; and because illness interferes with a person’s capacity to perform his or her normal 
social roles, it is a form of social deviance that is contained and rectified by means of an 
“institutionalized role or niche” (Williams 2005, p. 124). This role—the sick role—can be 
characterized as a contract or exchange between an individual and wider society, in which a 
person gains certain special permissions or exemptions in return for taking on certain 
responsibilities. The terms of the contract are roughly as follows: If someone is deemed to 
be legitimately sick, that person is exempted from his or her normal social obligations and 
from a degree of personal responsibility for the condition. However, these exemptions are 
“given at a price” (Parsons 1951, 151). The person has a responsibility not to linger in the 
sick role in order to take advantage of these exemptions; the person also is expected to seek 
medical assistance, to assume the transitional role of patient, and to cooperate with the 
physician in order to get well. The sick role has a set of complementary expectations that 
apply to physicians, who are essentially expected to competently apply their technical skills 
to facilitate a swift recovery (Williams 2005). 
Because Functionalist sociology frames sick people not as vulnerable but as a deviant 
element of a social system that needs to be contained, it sits somewhat uncomfortably 
within a bioethics context. The concept of the sick role nevertheless retains a degree of 
explanatory power (Williams 2005; Varul 2010), and it is particularly useful for our purposes 
because it has been the main means of theorizing—and thereby recognizing, describing, and 
accounting for—expectations that are placed on patients. This is important particularly 
because biomedical ethics is largely silent on such issues. In this article, we focus on the 
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expectations that are placed on sick persons, but we also discuss expectations surrounding 
the physician’s role in the consent process. 
Table 1 summarizes the foregoing discussion, showing the expectations placed on 
physicians and patients that derive from biomedical ethics and from the sick role, 
respectively.  
 
Table 1.  Role expectations placed on patients and on physicians 
Actor Theoretical Frame Role Expectations Explicit Implicit 
Patient Sick Role 
 Seek medical assistance 
when ill. 
x   
    
 Cooperate with physician to 
get better and do not linger 
in the sick role. 
x   
Physician Bioethics 
 Obtain patient’s consent 
before beginning treatment. 
x   
    
 Assure that patient’s 
consent is valid (i.e., given 
voluntarily, by a mentally 
competent person) and 
informed (i.e., given with 
disclosure and 
understanding). 
x   
Patient Sick Role / Bioethics 
 Participate in the consent 
process by demonstrating 
engagement in physician’s 
efforts to secure patient’s 
understanding. 
  x 
 
In essence, the sick role can be defined as “the set of patterned expectations that 
define the norms and values appropriate to being sick, both for the individual and others 
who interact with the person” (Cockerham and Ritchey 1997, p. 117). When social norms or 
expectations are not fulfilled, furthermore, trouble in social relationships commonly results. 
As Parsons points out, an important emphasis in social science “is on the factors responsible 
for ‘something’s going wrong’ in a person’s relationships to others during the process of 
social interaction” (1951, 148). Importantly, this proposition applies to the sick role itself. 
Thus, we can expect that trouble in relationships will arise when people do not conform to 
the sick role.  
Nonconformity with the sick role is an issue that has already received a lot of 
attention. For example, there is an extensive literature on problems surrounding 
noncompliance with (or nonadherence to) recommended medical regimens and treatment 
(e.g., DiMatteo et al. 2002; DiMatteo, Haskard, and Williams 2007). In addition, we contend 
that a different kind of trouble can and does arise in the lead up to and in the process of 
treatment, as a result of changing expectations that have emerged due to the practice of 
seeking informed consent for treatment. In what follows, we illustrate our argument 
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empirically with data from a set of interviews conducted in the bone-marrow 
transplantation setting, a context that is particularly fraught with concerns about informed 
consent because of the extreme nature of the treatment, the likelihood of serious side 
effects, and the high degree of uncertainty that attends decision-making.  
 
Methods 
Setting 
Allogeneic bone-marrow transplantation (hereafter simply BMT) is a complex sequence of 
procedures that involve a patient, a donor, and a team of health care professionals with 
highly specialized skills in an aggressive effort to treat advanced cancer and several other 
life-threatening conditions. BMT is an extremely challenging treatment for patients and is 
usually recommended only after previous treatments have been unsuccessful. Patients who 
undergo BMT face prolonged hospitalization, often in isolation, recurrent invasive medical 
procedures, and a range of severe and toxic side effects, which can themselves be life-
threatening. Professionals’ decisions to offer (or recommend) BMT, and patients’ decisions 
to consent to it, typically involve complex trade-offs between probable harms and benefits. 
Before raising the prospect of BMT with a patient, the transplant team considers 
whether the patient’s disease is treatable with BMT and then assesses whether the patient 
is an acceptable candidate for BMT from a medical point of view. Many of the procedures 
and entities involved in BMT will be entirely new to the vast majority of patients and are not 
commonly part of lay knowledge (e.g., human leucocyte antigen typing, stem cells, graft-
versus-host disease, and chimeras). Specialized professionals working in the BMT setting, 
therefore, go to considerable lengths to educate and inform patients as part of the consent 
process. These efforts occur in a context where the law and policy guidelines have had much 
to say about standards of disclosure, but very little about the problem of understanding.  
Participants, Data Collection, and Analysis 
The data reported here constitute part of a larger study designed to examine the principles 
and practices of those involved in the consent process in high-risk medical procedures. In 
this paper, we draw largely on interviews conducted with 16 health care professionals who 
specialize in the BMT setting. The study also included interviews with 16 patients, which we 
refer to here only in passing. Methods and findings related to the interviews with patients 
have been reported elsewhere (Forsyth et al. 2011).  
The health professionals in the study were sampled from the bone-marrow 
transplant units of three tertiary teaching hospitals in Sydney, Australia. A stratified, 
purposive sampling technique was used (Miles and Huberman 1994) in order to recruit 
individuals representing the various roles in the transplant team. These include the 
transplant hematologists (a subspecialty within hematology), who function as the transplant 
team leaders (n=7); and other members of the transplant team (n=9), who are involved in 
the consent process and patient care during and after the BMT procedure. These other 
team members included three nurses, two transplant coordinators, one care coordinator, 
one radiation oncologist, one patient representative, and one social worker.  
Participants were identified through the three study sites. The transplant 
hematologists were approached directly with a request for an interview. Next, the other 
transplant team members were identified through the BMT units, with input from the 
transplant team leaders; these potential interviewees also were approached directly with a 
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request for an interview. Of the health professionals approached for interviews, one 
declined to participate.  
Semi-structured interviews with the transplant hematologists focused on their 
interactions with patients during consultations. Topics included communication of the risks 
and benefits of the transplant, expectations of physicians and patients, patients’ 
involvement in the information exchange and decision-making process, and the 
responsibility patients had for their own health. Semi-structured interviews with the other 
transplant team members focused on their role in providing patients with information about 
the transplant and its side effects, the patients’ involvement in the process, and the role of 
family and support systems.  
Each participant was interviewed privately at the study site by a member of the 
research team. Interviews averaged one hour each. Interviews were digitally recorded, with 
interviewees’ permission, and professionally transcribed. To supplement the interviews, two 
of the authors attended patient education sessions at one of the hospitals as nonparticipant 
observers. Data were collected between 2007 and 2009. Ethics approval was obtained from 
the Human Research Ethics Committee (HREC) of the University of Sydney and the HRECs 
responsible for each of the participating hospitals, in accordance with ethical standards of 
Australia’s National Health and Medical Research Council.  
The authorship team systematically coded the interview data, using an interpretive 
approach that drew from the bioethics literature and the medical sociology literature, 
coupled with a keen awareness of emergent themes in the data related to the sick role 
within the context of consent. Thus, we tacked between the interviews and relevant 
theoretical literature to develop a set of codes and to hone our understanding of the 
observations reported next.  
 
Results 
Our study began after the patients had already sought medical assistance for their illness 
(the first expectation placed on patients, according to the sick role, as shown in Table 1). We 
are interested in the next set of expectations shown in Table 1 that pertain to the 
physician’s role and, subsequently, the patient’s role in the consent process. Thus, following 
Table 1, our observations from the interviews are organized according to the perceptions 
from the health care team about (a) expectations placed on physicians about their role in 
the consent process and (b) expectations placed on patients about their role in the consent 
process. In both cases, we provide evidence of reported behavior from interviewees that 
conforms to these expectations or fails to do so. We then present evidence of (c) 
intimations of trouble when expectations are not met. (In the quotes from our interviews, 
the letter H denotes quotes from the transplant hematologists, and the letters TM denote 
those from the other transplant team members.) 
Expectations Placed on Physicians  
Consistent with legal and bioethical requirements of informed consent, the transplant 
hematologists stated that they had a duty to inform patients about the complex procedures 
being considered and the serious, and potentially fatal, side effects: 
I feel it is my duty to convey to them the complexity and the potential 
complications (H3). 
 
 8 
 
I usually say, “I really, really need to talk to you about some potentially 
unpleasant things” (H1). 
 
When asked to describe the consent process, the interviewees referred to a range of 
activities and materials, including face-to-face meetings that are designed to allow 
substantial discussion between the patients and the health care team, with opportunities 
for questions and feedback, so as to maximize patient understanding. These discussions 
were reportedly customized to suit individual patients:   
The patients are so different that one conversation does not fit all (TM8).    
 
Consultations with transplant hematologists are routinely supplemented by 
interactions with other members of the transplant team, such as the transplant coordinator. 
Patients also are provided with electronic and printed materials (e.g., Bone Marrow 
Transplant Network NSW 2006) and are invited to attend information sessions at the 
hospital that combine formal presentations by members of the transplant team and 
transplant survivors, with informal opportunities to talk to the presenters. These 
information sessions are formally evaluated and are described elsewhere (Ferguson, 
Jordens, and Gilroy 2010).  
The transplant coordinator will probably be the main source of follow-up 
information and we have books, of course. There’s the transplant BMT network 
book. ... They’re encouraged to read [it] and then come back with question. … 
They’ll often meet with some of the ward nurses (H7). 
 
There’s an information leaflet. … In the BMT network book there is a list of 
recommended web sites (TM4). 
 
We also offer them an information session … and potential patients and their 
families are invited. … We have various speakers at that session. Nurses, social 
workers, former patients are there so they have the opportunity to speak to 
people who have gone through the process (H6). 
 
Expectations Placed on Patients  
Professionals’ expectations of the role of patients during the consent process were signaled 
by the use of strongly normative language (illustrated by our italics): 
The patient has to participate and cooperate. … So, you know, effort is their 
responsibility (H3). 
 
It should be compulsory that they come to the information day (TM3). 
 
We would expect that they have a responsibility to listen … to try to understand 
(H7). 
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The interviewees also described some of the behaviors that would indicate patients 
are fulfilling this role expectation for active engagement in the consent process. These 
behaviors included attending educational events, paying attention, listening, asking 
questions, and providing feedback. However, professionals commonly referred to these 
behaviors by noting their absence: 
Quite a few of us [transplant team members] spent a lot of time going through all 
of the things that I know his transplant specialist did go through with him 
[already], but he obviously wasn’t hearing it (TM4). 
 
I’ve been to consultations where they haven’t asked anything, even though we 
say, “Have you got any questions? Would you like something else explained? Do 
you understand?” (TM4).  
 
Some patients will say very specifically, “Don’t tell me about it, I don’t wanna 
know, I just wanna get through each day and then get out of here, I’ll deal with 
that as it gets there” (TM8). 
 
There was one young girl who, kind of, pulled the blankets up over her head 
almost when you try to talk to her (TM9). 
 
The interviewees also conceded, however, that patients faced serious obstacles due 
to their condition, the quantity and technicality of the information for them to assimilate, 
and the frightening and uncertain nature of the procedure. 
The patients interviewed for the study (reported elsewhere, Forsyth et al. 2011) 
were clearly aware of the efforts by the transplant team to educate and inform them. All 
were involved in consultations, were encouraged to attend education days, and received 
printed information, and each chose to engage with or ignore these educational measures 
according to their individual preferences. In fact, according to one evaluation, only 57 
percent of patients attended the information day sessions (Ferguson, Jordens, and Gilroy 
2010). These patients said nothing in their interviews that would indicate they were aware 
that the health care professionals treating them had strong expectations that the patients 
had a responsibility to engage with these educational measures, however. These 
expectations emerged only “off-stage” in research interviews where the health 
professionals evidently felt safe enough to vent their feelings about patients’ behavior, as 
we discuss next.  
Intimations of Trouble 
Even though some members of the transplant teams acknowledged the obstacles faced by 
patients, we observed several indications of potential trouble for patients, the transplant 
hematologists, and interpersonal relationships when patients did not appear to engage in 
the consent process. Although we found no direct evidence that trouble had actually 
occurred, we highlight observations that signal the potential for adverse consequences. For 
example, we observed critical and sometimes judgmental comments from the health care 
team reflecting their frustration with patients’ behavior during the consent process: 
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I mean, what can you do? All you can do, I mean, we feel that we’re obliged to 
explain some things, if she stops you telling her, then that’s her choice, or she 
can not listen (TM4). 
 
You can’t just hear the good news and not hear the bad. No life is like that (H6).  
 
Often they won’t ask me questions, so they let me rave on, which actually 
worries me a bit. … At the end, I say to them, “So let me just check something 
with you—you understand that you may die actually having this? This is pretty 
serious” (H3). 
 
If he says, “That’s not going to happen to me,” that would start alarm bells 
ringing, because then I would say this person does not have a realistic 
expectation about what will happen or what could happen (H1). 
 
There are clearly patients who don’t want to know anything, but I think it’s 
unreasonable, it’s an unreasonable expectation of me to take into a transplant a 
patient who hasn’t been told at least some very basic information (H1). 
 
Given such perceptions from the transplant hematologists and other members of the 
health care team, it is reasonable to infer that relationships between patients and the 
health care team could become strained when patients are deemed to have neglected their 
perceived responsibility to engage in the consent process. This in turn could adversely affect 
the psychosocial aspects of care.  
Another area of potential trouble flows from the frequently observed complaint 
from patients during the post-transplant recovery period that they were not adequately 
forewarned of what was to come (Little et al. 2008). Due to changes in the legal standards of 
disclosure, this kind of complaint touches on possible legal trouble for physicians (i.e., it 
could form grounds for a case of negligence against the physician on the basis of “failure to 
disclose material risks” [Kerridge, Lowe, and Stewart 2009, 149]). Thus, when this kind of 
complaint was discussed in the interviews, it triggered a defensive response by the health 
care professionals along the lines of “I warned you, but you didn’t listen”:   
[Recounting a conversation with a patient] Well, you know, you were given the 
option to come to the patient information day, you didn’t want to come—this 
would have all been explained for you at the patient information day (TM3). 
 
A man we had in here recently refused to read any information, he declined to 
come to the information day. … He felt that God would cure him, and then he got 
here and the whole process started. That’s when he started asking questions, 
and then he was giving the impression that he hadn’t been informed (TM4). 
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Sometimes afterwards patients will say, “If I’d known it was like this, I wouldn’t 
have done it.” I say, “Well, we talked about it, I showed you the pictures, I said 
you can die from this, you can’t get much sicker than that,” and they say, “Yeah, 
but I just didn’t realize it” (H7).  
 
While such attitudes suggest potential interpersonal trouble between patients and 
the health care team, they also bode ill for interpersonal relationships within the team itself. 
For example, although other members of the transplant team were actively involved in 
educating patients and providing them with information, these individuals clearly saw the 
informing role as primarily the transplant hematologist’s responsibility:  
I have no legal requirement to explain anything if I don’t want to. It’s not part of 
my role to totally educate, but I do (TM8). 
 
The consent process is expressly clinician to patient (TM1). 
 
Moreover, some of these team members dodged patients’ criticism by deflecting it 
to the transplant hematologists for being poor communicators and unapproachable to 
patients.  
[The transplant hematologists] have never learned. … They don’t have the skill 
[to communicate well]. … That’s the sadness: that people can be intellectually 
and academically so clever, but they can’t communicate with their patients. And 
that’s just so disheartening because you can do more harm than good (TM1). 
 
Depending on how approachable the doctors are and how clued in they are to 
the situation, you know sometimes they’re helpful and sometimes they’re not, 
quite honestly (TM2). 
 
They [the patients] may give the impression of understanding because they don’t 
want to look silly to the doctor. … They may not want the doctor to think I’m a bit 
stupid if I ask, “Well, what does that actually mean?” (TM8). 
 
In summary, the foregoing analysis of the interviews, guided by the theoretical 
elements of bioethics and the sick role as shown in Table 1, leads us to the following 
conclusions: (1) Health care professionals in the BMT setting recognize and act on 
expectations that they have a responsibility to inform and educate patients prior to 
treatment. (2) They expect patients to reciprocate by demonstrably engaging in the 
education process. (3) Patients are apparently unaware of this expectation and do not 
consistently act in a way that fulfills the expectation. (4) Not fulfilling it can lead to adverse 
consequences for patients, physicians, and interpersonal relationships within the clinic.  
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Discussion 
Historically, expectations placed on physicians have been codified in ethico-legal discourse, 
and expectations placed on patients have been codified separately in quasi-contractual 
terms in sociology through the notion of the sick role. Because both sets of expectations are 
brought to bear in the context of clinical relationships, however, shifts in one have 
implications for the other. Herein lies the rationale for considering consent and the sick role 
together. 
We have attempted to show how, in a particular clinical context, a shift in the 
expectations placed on physicians has affected those placed on patients. We began by 
observing that the consent process has become embedded in formal organizational 
practices and routines, both to satisfy legal requirements and to satisfy the underlying 
ethical principle of autonomy. We argued further that, whilst consent evolved initially as a 
reactive process designed to protect the autonomy of “essentially vulnerable” patients and 
research participants, it has increasingly functioned to augment patient autonomy rather 
than simply protect it. As health care professionals are increasingly expected (i.e., obliged) 
to attend to the informational elements of consent through greater disclosure of 
information and by ensuring that patients understand the information that is given to them, 
a more robust notion of consent has emerged (i.e., “informed” consent). Furthermore, 
because “informed” consent redresses the knowledge asymmetry that underpins the 
inequality in the physician–patient relationship, it also marks a shift in the relative social 
status of patient and physician roles.  
The impetus for this shift clearly relates to wide social, cultural, and juridical 
changes: Patients are increasingly educated, active in their own care, less deferential to 
medical authority, more protected by legal precedent, and so on. But however one seeks to 
explain the impetus, it is worth attending to its practical effects on the roles of physicians 
and patients.  
The Impact of “Informed” Consent on Professional Roles 
The shift to “informed” consent has meant that physicians (and health care professionals 
more generally) are increasingly expected to perform an educative role in the consent 
process. There is uncertainty about the scope of this role, however, especially with respect 
to gauging a patient’s understanding of the information being provided. For example, the 
American Medical Association’s policy on informed consent emphasizes the “physician’s 
obligation to present the medical facts accurately to the patient” and “to sensitively and 
respectfully disclose all relevant medical information to patients” (American Medical 
Association 1981, ¶1 and ¶2), but the policy is silent with regard to assuring patient 
understanding. The Veterans Health Administration’s Informed Consent Policy requires 
practitioners to “ensure that the patient indicates understanding of the information 
provided,” but only suggests that the practitioner “ask the patient to describe the 
recommended treatment or procedure in the patient’s own words” and “encourage the 
patient to ask questions” (Veterans Health Administration 2009, 9). Australia’s National 
Health and Medical Research Council (2004a, 2004b) has issued guidelines that suggest a 
range of communication strategies that make it more likely patients will understand the 
information that is proffered to them, but these guidelines are similarly vague on the 
question of how clinicians can or should gauge a patient’s actual level of understanding 
during the consent process. Despite the paucity of detail in these, and similar, policies on 
this point, the issue is one that concerns many in the practice of medicine, as evidenced by 
the growing body of research aimed at enhancing communication and measuring patient 
 13 
 
understanding (e.g., Flory and Emanuel 2004; Schenker et al. 2011; Schenker and Meisel 
2011).  
The Impact of “Informed” Consent on the Sick Role Contract 
Our analysis of consent in the BMT setting suggests that health care professionals in this 
clinical context expect patients to reciprocate the educational efforts that are increasingly a 
feature of the consent process by demonstrably engaging with them; and that if patients do 
not fulfill this expectation, trouble can result for both patients and the health care 
professionals involved in their care. The professionals’ expectations appear to be largely 
implicit, however, because their patients are apparently unaware of them. We thus propose 
that the long-standing behavioral norms of patients’ rights and responsibilities that 
constitute the sick role should be augmented by adding a new responsibility for patients: 
“that the patient should demonstrably engage with efforts of health care professionals to 
inform and educate them” during the consent phase of the doctor–patient relationship.  
It could be argued that this expectation falls under the general expectation, already 
encapsulated in the sick role, that patients should “cooperate” with their physician in order 
to get well. Whether patients understand “cooperation” to include trying to understand the 
information that is given to them is an open question. We would argue that “information 
needs” are widely framed and understood as a matter of preference, that preferences vary 
widely, and we suggest that many patients might be surprised to find that they are judged 
harshly for not trying hard enough to understand the information that is given to them. 
Whatever the truth of the matter, however, it is important to point out where expectations 
are changing, because the potential for “trouble in relationships” arises where expectations 
are not met. 
Trouble in the Gap 
It is one thing to give information and quite another to ensure that it is understood. 
Understanding does not depend solely on the efforts of health care professionals as 
information-givers; it demands an effort on the part of the patient as information-receivers. 
The “gap” between giving information and ensuring understanding has been somewhat 
obscured by the tendency to focus on what professionals should do in the consent process 
and ignore how patients respond to their initiatives. It is unrealistic to expect that there be 
no gap at all: As our interviewees recognized, aspects of the patient’s situation in BMT 
clearly work against understanding. But because a physician’s duty extends beyond mere 
disclosure to understanding, to ignore the gap entirely is effectively to ignore an element of 
consent and is therefore ethically unacceptable. The gap between disclosure and 
understanding is an expression of the rift between principle and practice and is thus a 
phenomenon that sits on the border of biomedical ethics and medical sociology. The 
frustration expressed by the health care professionals in our interviews provides a way to 
understand it: Frustration is a typical indication of an incomplete social process. In other 
words, obtaining “informed” consent can be understood as a process that is usually 
incomplete. 
Consent is commonly construed and widely understood as an “event” that is 
completed when a patient signs a document in the presence of a witness (usually a 
representative of the health care organization). We contend that the completeness is an 
illusion and that these documents only paper over a persistent, pedagogical problem. The 
notion of “implied” consent also provides a means of simulating closure of the process: If 
the patient turns up for the procedure, then consent is thereby assumed to have been 
given. Like a signature on a document, this enables the actors to all get on with the show. 
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But neither documents nor convenient assumptions assure that the patient’s consent has 
been given on the basis of understanding. It is revealing that the main clinic involved in this 
study did not use a standardized consent form that covered the entire BMT procedure. This 
does not mean the health care professionals were ignoring the requirement to obtain 
consent. On the contrary, their efforts to inform and educate patients were readily 
observable—not only as reported in their interviews, but also as evidenced by the 
educational forums they ran and the detailed book they distributed (Bone Marrow 
Transplant Network NSW 2006)—and their frustration at the incompleteness of the consent 
process is evidence of how seriously they viewed it.  
Implications for Education and Practice 
It serves our understanding of both the ethical and sociological dimensions of care to know 
where and how “trouble” arises and to seek explanations. Our analysis has important 
implications for health care professionals engaged in patient care, for those involved in 
teaching ethics and communication skills to health care professionals, and also for the 
operation of health care organizations. In order to obtain informed consent for high-risk 
procedures, it is necessary but not sufficient to design and execute work routines that yield 
a patient’s signature on a consent form. It is also important to recognize that health care 
professionals are faced with two distinct tasks in the consent process: One is to be explicit 
about their expectations concerning the patients’ role in the process; and the other is to try 
to educate patients about the treatment being proposed. As noted above, much has been 
written about the second task. There are numerous guidelines and interventions that are 
designed to improve the communication skills of health care professionals. Yet, to date, the 
literature has been silent on the need to ensure that patients are aware that they are 
expected to play a role in the consent process that extends beyond merely signing a consent 
form. Our research suggests that overlooking the first task can lead to trouble. 
In discussions with patients (and patients’ families and lay caregivers), health care 
professionals should therefore strive to be clear when they expect patients to actively 
engage with the education process. Although this is a simple point, it was evident in this 
study that patients were unaware of this expectation, and some might not have acted on it 
for that reason. Furthermore, health care professionals themselves might benefit from 
learning that their frustration around the consent process might be due to a perception that 
the process is incomplete.   
We recognize that this issue raises a paradox in high-risk settings such as BMT. 
Patients who need a bone marrow transplant are vulnerable because their life is at risk, and 
this can make it difficult for them to actively engage in the educational efforts of their 
professional carers. Yet, because of the considerable risks associated with treatment, it is 
crucial that they understand what they are consenting to. Our analysis thus raises a question 
for ongoing research: How can health care professionals effectively and sensitively facilitate 
the expanded role that is expected of patients in consent processes in high-risk settings?   
While our empirical investigation was confined to the BMT setting, the expectations 
we observed and the potential for trouble resulting from their nonfulfillment are likely to 
arise in similar clinical settings—that is, settings where patients are “consented” for 
procedures that are complex, where the risks and benefits of treatment are finely balanced, 
and where the stakes are high.  
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